Financing Drugs in South-East Asia - Report of the First Meeting of the WHO/SEARO Working Group on Drug Financing, Korat, Thailand, 26-28 November 1996 - Health Economics and Drugs Series No. 004
(1997; 72 pages) View the PDF document
Table of Contents
Open this folder and view contentsExecutive summary
Open this folder and view contents1. Introduction
Open this folder and view contents2. Country presentations on drug financing
Open this folder and view contents3. Korat provincial field visit
Open this folder and view contents4. Drug financing issues
Open this folder and view contents5. Country priorities for drug financing
Close this folder6. Priorities for work group action
View the document6.1 Group A
View the document6.2 Group B
Open this folder and view contents7. Conclusions and recommendations
View the documentAnnex A. Agenda
View the documentAnnex B. List of participants
View the documentAnnex C. List of documents
View the documentAnnex D. Message from Regional Director, WHO South-East Asia Region
Open this folder and view contentsAnnex E. Evaluation of the meeting. Priorities for the Working Group
 

6. Priorities for work group action

After each country had discussed its priorities, participants were paired into two groups; Group A (Thai-Indonesia) and Group B (Nepal-Myanmar) and they discussed tasks for work group action on priorities listed earlier. Abbreviations in parentheses indicate which countries chose particular issues as a priority.

TASKS

For each of the priority issues indicate:

1. What might be done at the country-level to address the issue?

2. What information-sharing or other actions involving the four countries and WHO would help to address the issue?

3. What should be done at the next Working Group meeting in terms of field visits, presentations, discussions, or other actions?

Summary of the two work groups:

to previous section to next section
 

Last updated: May 3, 2013